Lido Advisors LLC Takes Position in Tenet Healthcare Corporation $THC

Lido Advisors LLC acquired a new position in shares of Tenet Healthcare Corporation (NYSE:THC) in the 1st quarter, HoldingsChannel reports. The institutional investor acquired 2,263 shares of the company’s stock, valued at approximately $427,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Triumph Capital Management acquired a new position in Tenet Healthcare during the third quarter worth about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare during the 4th quarter worth approximately $29,000. Meeder Asset Management Inc. lifted its stake in Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at approximately $35,000. Institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Christopher S. Lynch sold 3,837 shares of the stock in a transaction on Monday, July 27th. The shares were sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the sale, the director directly owned 9,568 shares in the company, valued at $2,329,233.92. This represents a 28.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 33,353 shares of company stock worth $7,683,517. Company insiders own 0.97% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Truist Financial increased their price target on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday. Raymond James Financial set a $270.00 target price on Tenet Healthcare in a report on Monday. Robert W. Baird lifted their price target on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research note on Tuesday. Wells Fargo & Company boosted their price target on Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $268.50.

Tenet Healthcare Stock Up 0.9%

Shares of NYSE:THC opened at $254.88 on Friday. The firm has a market cap of $21.96 billion, a P/E ratio of 9.83, a P/E/G ratio of 0.96 and a beta of 1.27. Tenet Healthcare Corporation has a 12-month low of $156.71 and a 12-month high of $262.68. The business has a fifty day simple moving average of $192.10 and a 200 day simple moving average of $199.35. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the previous year, the company posted $4.02 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.